Evaluation of 18F-FDG PET/CT in early-stage cervical carcinoma

American Journal of the Medical Sciences

Volumn 341, Issue 2, 2011, Pages 96-100

  Yu, Lijuan ^a   Jia, Chengye ^a   Wang, Xin ^a   Lu, Peiou ^a   Tian, Mohan ^a   Wang, Wenzhi ^a   Lou, Ge ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

Cervical carcinoma; Deoxyglucose; Positron emission computed tomography; X ray computed tomography

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; FALSE NEGATIVE RESULT; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; PELVIS LYMPH NODE; PELVIS RADIOGRAPHY; PREDICTIVE VALUE; UTERINE CERVIX CARCINOMA; ADENOCARCINOMA; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; LABORATORY DIAGNOSIS; METASTASIS; MIDDLE AGED; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; RADIOGRAPHY; SCINTISCANNING; SQUAMOUS CELL CARCINOMA; UTERINE CERVIX TUMOR;

ADENOCARCINOMA; ADULT; CARCINOMA, SQUAMOUS CELL; FALSE NEGATIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS;

EID: 79951509268     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1097/MAJ.0b013e3181f48df6     Document Type: Article

References (16)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Grigsby PW, Herzog TJ. Current management ofpatients with inva-sive cervical carcinoma. Clin Obstet Gynecol 2001;44:531-7. (Pubitemid 32751774)
3. Jurado M, Galván R, Martinez-Monge R, et al. Neoangiogenesis in early cervical cancer: correlation between color Doppler findings and risk factors. A prospective observational study. World J Surg Oncol 2008;6:126.
4. Mittra E, E-Maghraby T, Rodriguez C, et al. Efficacy of 18F-FDG PET/CT in the evaluation ofpatients with recurrent cervical carcinoma. Eur J Nucl Med Mol Imaging 2009;36:1952-9.
5. Chung HH, Jo H, Kang WJ, et al. Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence. Gynecol Oncol 2007;104:529-34. (Pubitemid 46240239)
6. Park W, Park YJ, Huh SJ, et al. The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer. Jpn J Clin Oncol 2005;35: 260-4. (Pubitemid 41444292)
7. 18F-FDG uptake in squamous cell carcinoma of the cervix is correlatedwith glucose transporter 1 expres-sion. J Nucl Med 2004;45:22-9.
8. Chou HH, Chang TC, Yen TC, et al. Low value of [18F]-fluoro-2-deoxy-D- glucose positron emission tomography in primary staging of early-stage cervical cancer before radical hysterectomy. J Clin Oncol 2006;24:123-8.
9. Yen TC, Ng KK, Ma SY, et al. Value ofdual-phase 2-fluoro-2-deoxy-D- glucose positron emission tomography in cervical cancer. J Clin Oncol 2003;21:3651-8. (Pubitemid 46594059)
10. Horn LC, Hentschel B, Fischer U, et al. Detection ofmicrometastases in pelvic lymph nodes in patients with carcinoma of the cervix uteri using step sectioning: frequency, topographic distribution and prognos-tic impact. Gynecol Oncol 2008;111:276-81.
11. Wang HB, Wu SH, Wang ZH. Clinical outcome following radical hysterectomy and pelvic lymphadenectomy for early-stage cervical cancer. Chinese-German J Clin Oncol 2008;7:723-7.
12. Choi HJ, Roh JW, Seo SS, et al. Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma. Cancer 2006;106:914-22. (Pubitemid 43238460)
13. Selman TJ, Mann C, Zamora J, et al. Diagnostic accuracy oftests for lymph node status in primary cervical cancer: a systematic review and meta-analysis. CMAJ 2008;178:855-62. (Pubitemid 351482292)
14. Bentivegna E, Uzan C, Gouy S, et al. Correlation between [18f]flu-orodeoxyglucose positron-emission tomography scan and histology of pelvic nodes in early-stage cervical cancer. Anticancer Res 2010;30: 1029-32.
15. Sironi S, Buda A, Picchio M, et al. Lymph node metastasis in patients with clinical early-stage cervical cancer: detection with integrated FDG PET/CT. Radiology2006;238:272-9. (Pubitemid 43010605)
16. Chung HH, Park NH, Kim JW, et al. Role ofintegrated PET-CT in pelvic lymph node staging of cervical cancer before radical hysterec-tomy. Gynecol Obstet Invest 2009;67:61-6.